CIDRAP newsletters options
Infants in 10 states have been sickened, and all required hospitalization.
Trial investigators say the results could expand the scale and impact of mass drug administration campaigns against neglected tropical diseases.
The findings have implications for scheduling repeat dosing in eligible children, the authors say.
The rVSVΔG-LASV-GPC vaccine caused no serious adverse events and produced a strong immune response in healthy adults in the US and Liberia.
In Michigan, 113,000 birds were affected on a turkey farm in Ottawa County, the state's third detection in commercial turkeys in less than a week.
Texas health officials say the state has a seen a fourfold increase in whooping cough cases compared with last year.
The review will look at decades of data on the safety, efficacy, and public health impact of administering the hepatitis B shot at birth.
High-dose vaccine was 40% more effective against hospitalization than the standard-dose version.
Even without a booster, the vaccine triggered mucosal and systemic immunity, which other intranasal recombinant H5 flu vaccines have not achieved in clinical trials.
All but 46 of the confirmed cases have been in Senegal.
More than one third of the 10,007 bacterial isolates collected from 13 West Bank hospitals were classified as multidrug-resistant.
The deaths are likely due to poor health-seeking behavior among patients who seek medical intervention too late.
In a new report, the WHO says financing and access strategies need to be implemented to ensure the demand for future TB vaccines doesn't outstrip supply.
The measles outbreak along the Utah-Arizona border is the nation's second largest this year.
Over 6 months, COVID infection led to 2.24 extra cases of myocarditis or pericarditis per 100,000 children, versus 0.85 per 100,000 after vaccination.
The most common disease trajectories involved mental illnesses and neurologic, respiratory, and metabolic or digestive diseases.
The modeling study predicts the rate of drug-resistant BSIs will rise sharply in Europe over the next 5 years, driven primarily by an aging population.
The intravenous formulation of fosfomycin has a novel mechanism of action and no known cross-resistance to other antibiotic classes.
Data from a phase 2 randomized controlled clinical trial show ensitrelvir accelerated viral clearance in patients with early symptomatic COVID-19.
The authors noted that viral infections trigger the immune system to release substances that lead to inflammation and increase the risk of blood clots.
